(DUK) Duke Energy - Overview
Stock: Electricity, Natural Gas, Renewable Energy, Transmission
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.58% |
| Yield on Cost 5y | 6.87% |
| Yield CAGR 5y | 1.99% |
| Payout Consistency | 98.9% |
| Payout Ratio | 88.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.8% |
| Relative Tail Risk | 1.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.43 |
| Alpha | 7.45 |
| Character TTM | |
|---|---|
| Beta | -0.057 |
| Beta Downside | -0.015 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.48% |
| CAGR/Max DD | 0.93 |
Description: DUK Duke Energy January 28, 2026
Duke Energy Corp. (NYSE:DUK) operates two regulated segments in the United States: Electric Utilities & Infrastructure (EU&I), serving about 8.6 million electricity customers across the Southeast and Midwest, and Gas Utilities & Infrastructure (GU&I), delivering natural gas to roughly 1.7 million customers. The EU&I business generates power from a diversified mix-including coal, natural gas, nuclear, hydro, and expanding renewable assets-while also wholesaling electricity to municipalities and cooperatives. The GU&I segment focuses on gas distribution, pipeline transmission projects, renewable natural gas (RNG) development, and underground storage.
Key recent metrics (FY 2023): revenue $30.7 bn, net income $2.9 bn, and a regulated return on equity of ~9.5 % in the electric segment. Capital expenditures rose 12 % YoY to $5.2 bn, driven largely by renewable-energy and grid-modernization projects. The company’s debt-to-EBITDA ratio stands at 4.2×, reflecting a balance-sheet profile typical for capital-intensive utilities. Sector-wide, U.S. electricity demand is projected to grow ~1.5 % annually through 2028, while natural-gas consumption is expected to be volatile due to shifting fuel-mix preferences and ESG-related regulatory pressure.
For a deeper, data-rich analysis of DUK’s valuation dynamics, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 4.99b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 5.19 > 1.0 |
| NWC/Revenue: -22.64% < 20% (prev -17.49%; Δ -5.15% < -1%) |
| CFO/TA 0.06 > 3% & CFO 12.05b > Net Income 4.99b |
| Net Debt (88.54b) to EBITDA (15.78b): 5.61 < 3 |
| Current Ratio: 0.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (778.0m) vs 12m ago 0.65% < -2% |
| Gross Margin: 59.66% > 18% (prev 0.49%; Δ 5918 % > 0.5%) |
| Asset Turnover: 16.91% > 50% (prev 16.46%; Δ 0.46% > 0%) |
| Interest Coverage Ratio: 2.60 > 6 (EBITDA TTM 15.78b / Interest Expense TTM 3.56b) |
Altman Z'' 0.20
| A: -0.04 (Total Current Assets 12.21b - Total Current Liabilities 19.41b) / Total Assets 192.29b |
| B: 0.02 (Retained Earnings 4.72b / Total Assets 192.29b) |
| C: 0.05 (EBIT TTM 9.25b / Avg Total Assets 187.93b) |
| D: 0.04 (Book Value of Equity 4.90b / Total Liabilities 139.67b) |
| Altman-Z'' Score: 0.20 = B |
Beneish M -2.55
| DSRI: 1.76 (Receivables 4.01b/2.16b, Revenue 31.79b/30.21b) |
| GMI: 0.82 (GM 59.66% / 48.80%) |
| AQI: 1.02 (AQ_t 0.27 / AQ_t-1 0.27) |
| SGI: 1.05 (Revenue 31.79b / 30.21b) |
| TATA: -0.04 (NI 4.99b - CFO 12.05b) / TA 192.29b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of DUK shares?
Over the past week, the price has changed by +0.42%, over one month by +3.50%, over three months by -0.87% and over the past year by +10.26%.
Is DUK a buy, sell or hold?
- StrongBuy: 7
- Buy: 2
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DUK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 134.7 | 10.5% |
| Analysts Target Price | 134.7 | 10.5% |
| ValueRay Target Price | 137.1 | 12.5% |
DUK Fundamental Data Overview February 03, 2026
P/E Forward = 18.2149
P/S = 3.0212
P/B = 1.8938
P/EG = 2.5277
Revenue TTM = 31.79b USD
EBIT TTM = 9.25b USD
EBITDA TTM = 15.78b USD
Long Term Debt = 79.30b USD (from longTermDebt, last quarter)
Short Term Debt = 9.34b USD (from shortTermDebt, last quarter)
Debt = 89.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 88.54b USD (from netDebt column, last quarter)
Enterprise Value = 182.91b USD (94.37b + Debt 89.23b - CCE 688.0m)
Interest Coverage Ratio = 2.60 (Ebit TTM 9.25b / Interest Expense TTM 3.56b)
EV/FCF = 20.41x (Enterprise Value 182.91b / FCF TTM 8.96b)
FCF Yield = 4.90% (FCF TTM 8.96b / Enterprise Value 182.91b)
FCF Margin = 28.19% (FCF TTM 8.96b / Revenue TTM 31.79b)
Net Margin = 15.71% (Net Income TTM 4.99b / Revenue TTM 31.79b)
Gross Margin = 59.66% ((Revenue TTM 31.79b - Cost of Revenue TTM 12.82b) / Revenue TTM)
Gross Margin QoQ = none% (prev 29.75%)
Tobins Q-Ratio = 0.95 (Enterprise Value 182.91b / Total Assets 192.29b)
Interest Expense / Debt = 1.01% (Interest Expense 902.0m / Debt 89.23b)
Taxrate = 10.80% (176.0m / 1.63b)
NOPAT = 8.25b (EBIT 9.25b * (1 - 10.80%))
Current Ratio = 0.63 (Total Current Assets 12.21b / Total Current Liabilities 19.41b)
Debt / Equity = 1.73 (Debt 89.23b / totalStockholderEquity, last quarter 51.46b)
Debt / EBITDA = 5.61 (Net Debt 88.54b / EBITDA 15.78b)
Debt / FCF = 9.88 (Net Debt 88.54b / FCF TTM 8.96b)
Total Stockholder Equity = 50.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 4.99b / Total Assets 192.29b)
RoE = 9.83% (Net Income TTM 4.99b / Total Stockholder Equity 50.79b)
RoCE = 7.11% (EBIT 9.25b / Capital Employed (Equity 50.79b + L.T.Debt 79.30b))
RoIC = 6.04% (NOPAT 8.25b / Invested Capital 136.51b)
WACC = 3.37% (E(94.37b)/V(183.60b) * Re(5.71%) + D(89.23b)/V(183.60b) * Rd(1.01%) * (1-Tc(0.11)))
Discount Rate = 5.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.45%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈8.96b ; Y1≈5.88b ; Y5≈2.68b
Fair Price DCF = N/A (negative equity: EV 85.51b - Net Debt 88.54b = -3.03b; debt exceeds intrinsic value)
EPS Correlation: 50.61 | EPS CAGR: 19.09% | SUE: 0.87 | # QB: 1
Revenue Correlation: 65.47 | Revenue CAGR: 9.17% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.72 | Chg30d=+0.011 | Revisions Net=-3 | Analysts=10
EPS next Year (2026-12-31): EPS=6.70 | Chg30d=+0.001 | Revisions Net=-2 | Growth EPS=+6.1% | Growth Revenue=+3.8%